For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
New Year honours to acknowledge army of health workers
Wednesday 30 January 2019, 06:00 AM

Rob Stewart receives a New Year Honour for his services to children with genetic immune deficiency disorders
As a result of Dr Stewart’s work, diagnosis of primary/genetic immune deficiency disorders increased and early application of therapies was made possi
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
General Practice, Genetics, Surgery, Ophthalmology, University of Auckland